Literature DB >> 26883517

Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway.

Mao Mao1, Yanning Qian2, Jie Sun3.   

Abstract

To investigate the effect of morphine on T helper lymphocyte differentiation and PI3K/AKT pathway mechanism, CD4+ lymphocytes were treated by phorbol-myristate-acetate (25 ng/ml) (PMA) plus ionomycin (1 μg/ml) in the presence of various concentrations of morphine (25, 50, 100, 200 ng/ml) for 4 h. Th1 and Th2 subsets, supernatant cytokines, and PI3K, AKT, and protein kinase C-theta (PKC-θ) levels were detected. The Th1 cell percentage, Th1-derived cytokines, and ratio of Th1/Th2 decreased in the presence of morphine in a concentration-dependent manner. However, Th2 cell percentage kept stable after morphine treatment. The phosphorylation of PI3K and AKT decreased, but the phosphorylation of PKC-θ did not change in the presence of morphine. The decreased percentage of Th1 cells and ratio of Th1/Th2 was recovered by naloxone concentration-dependently. Morphine can inhibit the differentiation of Th1 lymphocytes and decrease the ratio of Th1/Th2 via the pathway of PI3K/AKT. The effect can be inhibited by naloxone.

Entities:  

Keywords:  PI3K/AKT; PKC-θ; T helper lymphocyte; Th1 cell; morphine

Mesh:

Substances:

Year:  2016        PMID: 26883517     DOI: 10.1007/s10753-016-0310-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

1.  Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3.

Authors:  Mei Gao; Jie Sun; Wenjie Jin; Yanning Qian
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period.

Authors:  Hala Abou Hammoud; Guy Aymard; Philippe Lechat; Nicolas Boccheciampe; Bruno Riou; Frédéric Aubrun
Journal:  Fundam Clin Pharmacol       Date:  2010-09-06       Impact factor: 2.748

3.  Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients.

Authors:  Hideyuki Ubukata; Gyou Motohashi; Takanobu Tabuchi; Hiroyuki Nagata; Satoru Konishi; Takafumi Tabuchi
Journal:  J Surg Oncol       Date:  2010-12-01       Impact factor: 3.454

4.  PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor.

Authors:  Sreedhar Madishetti; Nadine Schneble; Christian König; Emilio Hirsch; Stefan Schulz; Jörg P Müller; Reinhard Wetzker
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

5.  New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin.

Authors:  Rong Ding; Jinshan Tang; Hao Gao; Ting Li; Hua Zhou; Liang Liu; Xin-Sheng Yao
Journal:  Arch Pharm Res       Date:  2012-10-09       Impact factor: 4.946

Review 6.  Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Authors:  K L Knutson; M L Disis
Journal:  Cancer Immunol Immunother       Date:  2005-01-27       Impact factor: 6.968

7.  Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway.

Authors:  Sayaka Higuchi; Masaaki Ii; Ping Zhu; Muhammad Ashraf
Journal:  Circ J       Date:  2011-10-28       Impact factor: 2.993

8.  Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.

Authors:  Kristy M Greeneltch; Ann E Kelly-Welch; Yufang Shi; Achsah D Keegan
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

9.  Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes.

Authors:  Jürgen Kraus
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

10.  Regulation of mu opioid receptor expression in developing T cells.

Authors:  Lily Zhang; Judith Sliker Belkowski; Tammi Briscoe; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

View more
  3 in total

1.  Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery.

Authors:  Xudong Hu; Bing Luo; Qing Wu; Qingbiao Chen; Penghui Lu; Jie Huang; Xiaoxia Liang; Cheng Ling; Yiqun Li
Journal:  Drug Des Devel Ther       Date:  2021-12-02       Impact factor: 4.162

2.  Sufentanil postoperative analgesia reduce the increase of T helper 17 (Th17) cells and FoxP3+ regulatory T (Treg) cells in rat hepatocellular carcinoma surgical model: A randomised animal study.

Authors:  Yanhua Peng; Jinfeng Yang; Duo Guo; Chumei Zheng; Huiping Sun; Qinya Zhang; Shuangfa Zou; Yanping Zhang; Ke Luo; Keith A Candiotti
Journal:  BMC Anesthesiol       Date:  2020-08-26       Impact factor: 2.217

Review 3.  Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.

Authors:  Christopher C Phelps; Christopher M Walker; Jonathan R Honegger
Journal:  Viruses       Date:  2021-07-13       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.